Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
INmune Bio Inc
Swot
INmune Bio Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
INmune Bio Inc has 11 Strengths, 8 Weaknesses, 3 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(11)
Weakness
(8)
Opportunity
(3)
Threats
(1)
Others
(1)
MACD Crossover Above Signal Line
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over the Quarter (3 Months)
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Month
MACD crossed above signal line previous end of day
Companies with Low Debt
Top Gainers
Stock with Low PE (PE < = 10)
Stocks Outperforming their Industry Price Change in the Quarter
Stocks in downtrend most likely to cross below SMA-200 soon
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Inefficient use of shareholder funds - ROE declining in the last 2 years
Inefficient use of assets to generate profits - ROA declining in the last 2 years
Degrowth in Quarterly Revenue and Profit in Recent Results(YoY)
Low Piotroski Score : Companies with weak financials
Annual net profit declining for last 2 years
Book Value Per Share deteriorating for last 2 years
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mutual Funds Decreased Shareholding in Past Month
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
